Success Stories: North America Immigration Law Group Gets Hired to Help with EB1-A Case, Obtains Approval for Indian Research Associate in Microbiology with 1,010 Citation Count
Client’s Testimonial:
“We are really very happy to know that it got approved in such a short time, and the credit goes to your excellent petition drafts. You take utmost care to write these letters for us to highlight our achievements in the best possible way which helps us get the approvals without any hassle. I am very thankful to both the attorneys who drafted my EB1-B and EB1-A petitions and recommendation letters, along with all other attorneys who responded to my frequent queries all these several months.”
On March 26th, 2022, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Associate in the Field of Microbiology (Approval Notice).
General Field: Microbiology
Position at the Time of Case Filing: Research Associate
Country of Origin: India
Country of Residence at the Time of Filing: India
Approval Notice Date: March 26th, 2022
Processing Time: 4 months, 8 days (Premium Processing Requested)
Case Summary:
Our alien of extraordinary ability (EB1-A) client from India was one of the few leading viral infection experts in microbiology. He had achieved a consistent and notable record of success and influence in this area of study and was especially well-known for conducting an epidemiological investigation on circulating strains of influenza during the 2009 H1N1 pandemic and post-pandemic period. His work in this area helped to improve the diagnosis of influenza patients and provided his peers with a novel antiviral approach and molecular gene-silencing strategy.
Our team noted that he has spent years investigating issues related to viral infection and is regarded as an authority in the field. The field has recognized his authority by inviting him to review and evaluate the work of his peers no fewer than 70 times. In addition to directly advancing viral infection studies through his original research and peer review service, he has actively engaged his peers in the field of microbiology by authoring and co-authoring 40 peer-reviewed articles and 6 book chapters that have been published in international journals. Additionally, his overall work related to the improvement of viral infection research and treatment has been cited 1,010 times by peers using his prior findings to make additional discoveries related to influenza A virus, etc.
In fact, he is one of the top 1% of most highly cited authors publishing on topics in microbiology and virology over the past 10 years according to Microsoft Academic. At the same time, these publications have been cited by researchers in at least 50 countries according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of microbiology.
He also received funding to support his research on this project from the U.S. Centers for Disease Control and Prevention through the Indian Council of Medical Research in India. His extraordinary accomplishments are hence strongly based on his extensive knowledge and experience in the field. This fact was also corroborated by 4 letters of recognition written by experts in support of his work. One of them said:
“The tremendous variance in seasonal influenza, combined with the fact that, though it is an almost annual reoccurrence, it still kills hundreds of thousands of people each year, makes the treatment of the virus an extremely salient topic for global public health concerns. [Client’s] research on the influenza virus is therefore invaluable for safeguarding human health.”
With these facts in place, our team tried its best to convince the adjudicating authorities at the USCIS to consider this petition and the accompanying evidence and approve this request for an employment-based immigrant visa. We thank our client for his trust and support and for retaining us to file his EB1-A petition. We wish him the very best in all future endeavors.